Markus Wagener

Title: Innovations of Markus Wagener

Introduction

Markus Wagener is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. With a total of 2 patents to his name, Wagener's work is focused on addressing medical challenges through innovative solutions.

Latest Patents

Wagener's latest patents include two key inventions. The first patent, titled "Substituted pyrazole amides," relates to compounds that act as inhibitors of Na1.8 and can be utilized in the treatment of pain. The second patent, "6-membered cyclic amines or lactames substituted with urea and phenyl," describes a compound that serves as a modulator of FPR2, which can be used in the treatment and/or prophylaxis of disorders mediated by FPR2.

Career Highlights

Markus Wagener is currently employed at Grünenthal GmbH, a company known for its focus on pain management and innovative pharmaceutical solutions. His work at Grünenthal has allowed him to explore and develop new therapeutic compounds that have the potential to improve patient outcomes.

Collaborations

Wagener collaborates with talented colleagues, including Sebastian Krueger and Sebastian Peil. These collaborations enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Markus Wagener's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly impact patient care.